Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer (SORAMIC)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Bayer
Sirtex Medical
Information provided by (Responsible Party):
Jens Ricke, University of Magdeburg
ClinicalTrials.gov Identifier:
NCT01126645
First received: May 17, 2010
Last updated: December 2, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)